| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
| mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
| mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
| mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
| mRNA |
GSK2126458 |
GDSC1000 |
pan-cancer |
AAC |
-0.0025 |
0.9 |